Peetz Christopher — SEC insider filings
SEC reporting owner CIK 1614740. 48 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers all 48 filings on record, filed 2020-11-12 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 3 filings — 13,900 shares, $213,603 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 34 legs across 22 filings — 382,180 shares, $27,590,089 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 73.
- Largest priced transaction: sale of 40,985 shares @ $91.98 ($3,769,714) in Mirum Pharmaceuticals, Inc., filed 2026-03-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER, Director | 40 | 3 legs · 12,000 sh · $194,280 | 33 legs · 380,280 sh · $27,570,766 | 58 |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) | Director | 7 | 1 leg · 1,900 sh · $19,323 | 1 leg · 1,900 sh · $19,323 | 12 |
| Arcutis Biotherapeutics, Inc. (ARQT) | Director | 1 | — | — | 3 |
Insider filings — Peetz Christopher
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 20,000 @ $2.94 · Sale (S): 20,000 @ $90 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-10-06 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 5,305 @ $19.19 · Option exercise (M): 6,892 @ $15.87 · Option exercise (M): 5,305 (derivative) @ $0 · Option exercise (M): 6,892 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 30,000 @ $2.94 · Sale (S): 8,312 @ $98.08 · Sale (S): 21,688 @ $98.91 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-08-11 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 20,000 @ $2.94 · Sale (S): 11,683 @ $98.51 · Sale (S): 6,017 @ $99.25 · Sale (S): 2,300 @ $100.14 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 4,315 @ $0 · Grant/award (A): 21,486 (derivative) @ $0 · Grant/award (A): 13,010 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 20,000 @ $2.94 · Sale (S): 12,134 @ $121.65 · Sale (S): 4,181 @ $122.34 · Sale (S): 1,975 @ $123.74 · Sale (S): 1,710 @ $124.79 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 30,000 @ $2.94 · Sale (S): 2,602 @ $94.64 · Sale (S): 16,595 @ $95.34 · Sale (S): 6,926 @ $96.15 · Sale (S): 1,973 @ $97.56 · Sale (S): 1,021 @ $98.20 · +2 more | EDGAR |
| 2026-03-17 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 25,000 · Option exercise (M): 50,000 · Sale (S): 40,985 @ $91.98 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 9,108 @ $103.30 | EDGAR |
| 2026-01-30 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 67,000 (derivative) @ $0 · Grant/award (A): 43,500 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 12,500 · Sale (S): 6,831 @ $96.19 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 12,797 · Sale (S): 7,098 @ $93.33 · Option exercise (M): 12,797 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Gift (G): 21,070 @ $0 | EDGAR |
| 2025-11-20 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 19,133 @ $19.24 · Option exercise (M): 19,133 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 40,000 @ $2.94 · Sale (S): 40,000 @ $62 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 40,000 @ $2.94 · Sale (S): 40,000 @ $55.25 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 50,000 · Sale (S): 27,279 @ $44.21 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 40,000 @ $2.94 · Sale (S): 19,392 @ $46.61 · Sale (S): 20,608 @ $47.19 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 9,102 @ $48.22 | EDGAR |
| 2025-01-27 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 12,500 · Sale (S): 6,837 @ $47.92 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 153,550 (derivative) @ $0 · Grant/award (A): 38,390 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 7,489 @ $42.82 | EDGAR |
| 2024-11-14 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 65 @ $21.05 | EDGAR |
| 2024-07-24 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 34,013 @ $2.94 · Option exercise (M): 34,013 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Disposition to issuer (D): 1,900 · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +2 more | EDGAR |
| 2024-05-16 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 817 @ $21.05 | EDGAR |
| 2024-03-18 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 5,159 @ $20.62 | EDGAR |
| 2024-02-05 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 6,013 @ $26.19 | EDGAR |
| 2024-01-25 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 5,209 @ $28.03 | EDGAR |
| 2024-01-04 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-07-05 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 5,498 @ $25.65 | EDGAR |
| 2023-05-19 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 1,256 @ $16.92 | EDGAR |
| 2023-02-02 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-11-14 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 49 @ $17.05 | EDGAR |
| 2022-05-12 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 1,500 @ $13.57 | EDGAR |
| 2022-01-07 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 40,000 @ $0 · Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2021-11-29 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Purchase (P): 7,000 @ $14.40 | EDGAR |
| 2021-10-01 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 21,875 @ $0 · Sale (S): 3,672 @ $19.26 | EDGAR |
| 2021-09-27 | 4/A | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Purchase (P): 1,900 @ $10.17 | EDGAR |
| 2021-09-24 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Sale (S): 1,900 @ $10.17 | EDGAR |
| 2021-05-12 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 1,453 @ $14.62 | EDGAR |
| 2021-01-11 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Grant/award (A): 7,650 (derivative) @ $0 | EDGAR |
| 2020-12-28 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Purchase (P): 3,000 @ $18.76 · Purchase (P): 2,000 @ $18.60 | EDGAR |
| 2020-11-12 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 1,371 @ $15.27 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1614740 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs